MarketInOut Stock Screener Log In | Sign Up

Alebund Pharmaceuticals (Jiangsu) Ltd

HKSE • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
Alebund Pharmaceuticals (Jiangsu) Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeHKSE
Market Capitalization5,692.29 mln
Float110 mln

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-0.86
Highly suspicious

1-Year Forecast

48.72
Transformational upside

Relative Strength

16 / 100
Significantly lagging

Debt / Equity

0.41
Low leverage

Pre-Tax Margin

-530%
Severely loss-making

Business Description

Alebund Pharmaceuticals is a China-based drug development company focused on treating kidney disease and related conditions, operating primarily in China and Hong Kong. Founded in 2018 and headquartered in Yangzhou, the company has built a pipeline of several drug candidates at various stages of development, ranging from early clinical trials to preclinical research. Its most advanced products target the way the body manages phosphate, which is a key concern for patients with kidney conditions.

Key Fundamentals

EPS-2.41
ROE-428
ROIC-41.41
ROA-42.72
EBITDA, mln-630
EV / EBITDA-8.22
EV / EBIT-7.60
Revenue, mln139
EV / Revenue37.30

Quote Details

Last 16.14
Change -0.6 (-3.58%)
Open 16.74
Volume 210,562
Turnover 3,398,470
Average Volume 1,043,190

Financial Ratios

Pre-Tax Profit Margin-530
Current Ratio9.81
Price / Book5.22
Price / Tangible Book5.25
Debt / Equity0.41
Price / Sales52.26

Financial Strength

Altman Z-Score2.98
Piotroski F-Score 7 / 9
Beneish M-Score-0.86
1-Year Target Price48.72

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.53% 82 / 100   
1 Month -34.66% 5 / 100   
2 Months -44.19% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog